{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:41:31Z","timestamp":1791200491358,"version":"4.2.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.tox.2012.01.015","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T12:48:15Z","timestamp":1328532495000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: Evaluation of eryptotic pathway"],"prefix":"10.1016","volume":"294","author":[{"given":"Shobana","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan D.","family":"Chaurasiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu L.","family":"Tekwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2012.01.015_bib0005","first-page":"177","article-title":"The hemolytic effect of primaquine. III. A study of primaquine sensitive erythrocytes","volume":"44","author":"Beutler","year":"1954","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.tox.2012.01.015_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1182\/blood.V80.1.255.255","article-title":"New glucose-6-phosphate dehydrogenase mutations from various ethnic groups","volume":"80","author":"Beutler","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.tox.2012.01.015_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/clpt.1983.54","article-title":"Microsomal incubation test of potentially hemolytic drugs for glucose-6-phosphate dehydrogenase deficiency","volume":"33","author":"Bloom","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2012.01.015_bib0020","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.95.6.3077","article-title":"Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia","volume":"95","author":"Boas","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tox.2012.01.015_bib0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0006-2952(86)90144-9","article-title":"Oxidative activity of hydroxylated primaquine analogs","volume":"35","author":"Baird","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0006-2952(86)90145-0","article-title":"Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intach human and red blood cells in vitro","volume":"35","author":"Baird","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/CMR.00051-10","article-title":"Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination","volume":"24","author":"Bousema","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tox.2012.01.015_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/jpet.103.062984","article-title":"Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine","volume":"309","author":"Bowman","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2012.01.015_bib0045","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.105.086488","article-title":"Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine","volume":"314","author":"Bowman","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2012.01.015_bib0050","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1124\/jpet.105.090407","article-title":"Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes","volume":"315","author":"Bowman","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2012.01.015_bib0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/1475-2875-9-376","article-title":"The reality of using primaquine","volume":"9","author":"Burgoine","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.tox.2012.01.015_bib0060","first-page":"391","article-title":"Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug","volume":"59","author":"Clyde","year":"1981","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.tox.2012.01.015_bib0065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1113\/jphysiol.2001.013040","article-title":"Oxidation induces a Cl(\u2212)-dependent cation conductance in human red blood cells","volume":"539","author":"Duranton","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.tox.2012.01.015_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1475-2875-10-351","article-title":"Primaquine in vivax malaria: an update and review on management issues","volume":"10","author":"Fernando","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.tox.2012.01.015_bib0075","first-page":"600","article-title":"The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity","volume":"51","author":"Flanagan","year":"1958","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.tox.2012.01.015_bib0080","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/0006-2952(88)90263-8","article-title":"Studies n the mechanism of oxidation in the erythrocytes by metabolites of primaquine","volume":"37","author":"Fletcher","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000233238","article-title":"Suicide for survival\u2014death of infected erythrocytes as a host mechanism to survive malaria","volume":"24","author":"F\u00f6ller","year":"2009","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tox.2012.01.015_bib0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.taap.2009.07.012","article-title":"Cytochrome P450-dependent toxic effects of primaquine on human erythrocytes","volume":"15","author":"Ganesan","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jat.1493","article-title":"Cytochrome P450-dependent toxicity of dapsone in human erythrocytes","volume":"30","author":"Ganesan","year":"2010","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2012.01.015_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0090-9556(25)06501-8","article-title":"Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents","volume":"23","author":"Idowu","year":"1995","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.tox.2012.01.015_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.1980.tb05937.x","article-title":"Membrane characteristics and metabolic properties of glucose-6-phosphate dehydrogenase deficient red cells","volume":"46","author":"Jansson","year":"1980","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tox.2012.01.015_bib0110","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/0006-2952(82)90537-8","article-title":"Primaquine-mediated oxidative metabolism in the human red cell. Lack of dependence on oxyhemoglobin, H2O2 formation, or glutathione turnover","volume":"31","author":"Kelman","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1113\/jphysiol.1996.sp021572","article-title":"Oxidized glutathione mediates cation channel activation in calf vascular endothelial cells during oxidant stress","volume":"495","author":"Koliwad","year":"1996","journal-title":"J. Physiol."},{"key":"10.1016\/j.tox.2012.01.015_bib0120","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1089\/ars.2006.8.1183","article-title":"Mechanisms and significance of eryptosis","volume":"8","author":"Lang","year":"2006","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.tox.2012.01.015_bib0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000185448","article-title":"Eryptosis, a window to systemic disease","volume":"22","author":"Lang","year":"2008","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tox.2012.01.015_bib0130","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1152\/ajpcell.00186.2003","article-title":"Role of Ca2+-activated K+ channels in human erythrocyte apoptosis","volume":"285","author":"Lang","year":"2003","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.tox.2012.01.015_bib0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0041-008X(85)90155-3","article-title":"Structure\u2013activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates","volume":"81","author":"Link","year":"1985","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1413-8670(10)70084-2","article-title":"Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon","volume":"14","author":"Ramos","year":"2010","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.tox.2012.01.015_bib0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00139709-200423030-00004","article-title":"Oxidant stress and haemolysis of the human erythrocyte","volume":"23","author":"Sivilotti","year":"2004","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.tox.2012.01.015_bib0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2125.1978.tb00858.x","article-title":"Studies with primaquine in vitro: superoxide radical formation and oxidation of haemoglobin","volume":"6","author":"Summerfield","year":"1978","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-200427010-00003","article-title":"Antimalarial drug toxicity: a review","volume":"27","author":"Taylor","year":"2004","journal-title":"Drug. Saf."},{"key":"10.1016\/j.tox.2012.01.015_bib0165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QCO.0b013e328010b848","article-title":"8-Aminoquinolines: future role as antiprotozoals","volume":"19","author":"Tekwani","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.tox.2012.01.015_bib0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tox.2012.01.015_bib0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.taap.2010.01.017","article-title":"Blood cell oxidative stress precedes hemolysis in whole blood\u2013liver slice co-cultures of rat, dog, and human tissues","volume":"244","author":"Vickers","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2012.01.015_bib0180","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1016\/S0021-9258(19)50504-X","article-title":"Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling","volume":"267","author":"V\u00e1squez-Vivar","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2012.01.015_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.tox.2012.01.015_bib0190","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11536520-000000000-00000","article-title":"Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review","volume":"33","author":"Youngster","year":"2010","journal-title":"Drug Saf."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X1200025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X1200025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:19:11Z","timestamp":1759533551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X1200025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0300483X1200025X"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2012.01.015","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: Evaluation of eryptotic pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2012.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}